Ponesimod tablets bulk supplier for pharma manufacturers

Ponesimod Tablets 20 mg Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 20 mg

Reference Brands: Ponvory(US & EU)

Ponesimod is a selective sphingosine-1-phosphate receptor modulator that prevents lymphocyte migration, reducing neuroinflammation. It decreases relapse rates and slows disease progression in multiple sclerosis. Benefits include oral dosing, targeted immune regulation, reduced relapse frequency, and improved quality of life for patients with relapsing MS.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Ponesimod, marketed as Gilyea, is approved in the US by the FDA and in the EU via EMA for relapsing multiple sclerosis (MS). Regulatory approval requires a detailed dossier including clinical efficacy, safety data, manufacturing quality, and pharmacovigilance plans. In the US, FDA review involves comprehensive analysis of clinical trial results and manufacturing standards, while the EMA ensures compliance with regional safety and quality regulations.

Ponesimod Tablets — third party manufacturing & bulk supply

Ponesimod Tablets 20 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Ponesimod Tablets is supplied as Tablet — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Ponesimod Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Ponesimod Tablets →

Back to Listing

Frequently Asked Questions

Ponesimod tablets is listed as Tablet in 20 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Ponesimod tablets is referenced against Ponvory(US & EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.